Vertex Pharmaceuticals

VRTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$132.791 B

$523.91 +5.61%

Close of 10 Aug 2026

Revenue

$12.0B

#369 by revenue

Earnings

$3.95B

#130 by earnings

Shares outstanding

253,460,924

Latest filing cover page

P/E ratio

33.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#8Abbott LaboratoriesABT$188.0B
#9PfizerPFE$154.2B
#10Vertex PharmaceuticalsVRTX$132.8B
#11Bristol Myers SquibbBMY$132.4B
#12SanofiSNY$106.0B

Where these numbers come from

Share counts and financials for Vertex Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Aug 2026. Read the methodology.